RAD‑140 (Testolone)
An experimental muscle-building SARM; not approved as a medicine, severe liver damage has been reported, banned in sport.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons
Ostarine vs RAD-140DETAILED OVERVIEW
What is RAD-140 (Testolone)?
RAD-140 (Testolone) is an experimental compound, a so-called SARM (selective androgen receptor modulator), that mainly imitates the effect of testosterone in muscle and bone. It has not been approved as a medicine anywhere: only a few small studies have been done in humans, the results were not convincing enough, and development was stopped. It is sold as a research chemical and is banned in competitive sport all year round.
Its most serious known risk is liver damage: six documented cases have been described, some of them close to needing a liver transplant. It strongly suppresses the body's own testosterone production, which can cause tiredness, lower sex drive and shrinking testicles, and fertility drops temporarily. It lowers HDL cholesterol (the beneficial kind), and in women it can cause irreversible masculinization. It must not be used in pregnancy or breastfeeding, because it can masculinize the baby.
Mechanism
Non-steroidal selective AR modulator (anilide). Strong AR agonist in muscle + bone, weaker in prostate.
Anabolic activity (Miller 2011)
About 80% of testosterone's effect in muscle, about 30% in the prostate
Half-life
~16-20 h (oral)
Onset
1-2 weeks (anecdotal strength gain)
Legal status
Never an Rx (Phase II stalled). UGL market 'research chemical'. USA Schedule III analog in some states from 2018. WADA-banned.
Anecdotal reports describe RAD-140 as one of the more potent SARMs, with users reporting it feels closer to a 'mild steroid' than a typical SARM. Community accounts describe good results from protocols like 20 mg RAD-140 for 6 weeks alongside a low-dose testosterone base around 350 mg/week. Most experienced users do not recommend running SARMs without a testosterone base, though it is technically possible. Despite being marketed as 'selective,' RAD-140 will suppress natural testosterone. It is a solid muscle-builder mg-for-mg, sometimes reported as stronger than Anavar. Because it is taken orally and undergoes liver metabolism, it negatively impacts lipids and adds hepatic strain, similar to other oral compounds. Some users report aggression and insomnia, though this is highly individual. Hair loss has also been reported. Lower doses can be very effective due to high androgen-receptor affinity.
⚠ Not clinical evidence – based on user accounts.
Data console
Lab data
Miner JN, Chang W, Chapman MS, Finn PD, Hong MH, López FJ, Marschke KB, Rosen J, Schrader W, Turner R, Van Oeveren A, Viveros H, Zhi L, Negro-Vilar A . An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.. Endocrinology.
LoRusso P, Hamilton E, Ma C, Vidula N, Bagley RG, Troy S, Annett M, Yu Z, Conlan MG, Weise A . A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.. Clin Breast Cancer.
Leung K, Yaramada P, Goyal P, Cai CX, Thung I, Hammami MB . RAD-140 Drug-Induced Liver Injury.. ACG Case Rep J.
Labban H, Kwait B, Paracha A, Khan A, Singh M, Lopez R . LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults.. Cureus.
Vasilev V, Georgieva K, Kraeva M . Selective Androgen Receptor Modulators in Women: What Do We Know, and What Is Still Missing.. Life (Basel).
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Hepatotoxicity (drug-induced liver injury, DILI): as an oral SARM, multiple documented case reports show ALT/AST elevations >10x, cholestatic/hepatocellular jaundice, and acute liver failure in severe cases.
- HPTA suppression: strong suppression of endogenous testosterone, LH and FSH production (~80% after 6-8 weeks), which can cause fatigue, low libido and testicular atrophy.
- Adverse lipid shift: marked drop in HDL (good) cholesterol (~30-50%), raising long-term cardiovascular risk.
- Reduced fertility: temporary suppression of spermatogenesis; full HPTA recovery may take 3-6 months after the cycle.
- Mood and sleep disturbances: anecdotally increased aggression, irritability and insomnia, with strongly individual severity.
- Androgenic effects: hair thinning/androgenic alopecia in predisposed users, increased sebum and acne.
- Slow clearance: with a ~16-20 hour half-life, the compound cannot be cleared quickly if adverse effects appear, and effects can persist for days.
Contraindications · 7
- Any pre-existing liver disease or already elevated ALT/AST/bilirubin: absolute contraindication given the documented DILI risk.
- Concurrent alcohol use or other hepatotoxic agents (other oral SARMs, 17-alpha-alkylated steroids, high-dose paracetamol): cumulative liver burden.
- Pregnancy and breastfeeding: risk of fetal virilization from androgenic activity, absolute contraindication.
- Women, especially at higher doses: risk of irreversible virilization (voice deepening, hirsutism, clitoral enlargement).
- Planned fatherhood in the near term: HPTA suppression and recovery of spermatogenesis can take up to 3-6 months.
- Pre-existing dyslipidemia or cardiovascular disease: HDL reduction further worsens the lipid profile and CV risk.
- Competitive athletes: banned year-round by WADA (S1.2 other anabolic agents), with a 3-6 week urinary detection window.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Miner JN, Chang W, Chapman MS, Finn PD, Hong MH, López FJ, Marschke KB, Rosen J, Schrader W, Turner R, Van Oeveren A, Viveros H, Zhi L, Negro-Vilar A
A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
LoRusso P, Hamilton E, Ma C, Vidula N, Bagley RG, Troy S, Annett M, Yu Z, Conlan MG, Weise A
RAD-140 Drug-Induced Liver Injury.
Leung K, Yaramada P, Goyal P, Cai CX, Thung I, Hammami MB
LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults.
Labban H, Kwait B, Paracha A, Khan A, Singh M, Lopez R
Selective Androgen Receptor Modulators in Women: What Do We Know, and What Is Still Missing.
Vasilev V, Georgieva K, Kraeva M
Telegram
Have a question about RAD‑140 (Testolone)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.

